Why the study?
The study evaluated the association of A-FABP with obesity and whether its levels decrease after laparoscopic omega loop gastric bypass as an indicator of metabolic syndrome improvement.
Does laparoscopic omega loop gastric bypass reduce A-FABP levels and improve metabolic syndrome markers in morbid-obese patients?
Does laparoscopic omega loop gastric bypass reduce A-FABP levels and improve metabolic syndrome markers in morbid-obese patients?
Laparoscopic omega loop gastric bypass significantly reduces A-FABP levels and improves metabolic syndrome markers in morbidly obese patients at 1 year.
A-FABP reduction after omega loop bypass was associated with weight loss; hypothesis-generating and should not yet change practice pending RCTs.
Introduction: A-FABP (Adipocyte fatty acid-binding protein) has been shown to affect lipid metabolism, insulin sensitivity, and lipolysis furthermore, studies also found that A-FABP is a key mediator for obesity-related cardiovascular disease and is usually associated with metabolic syndrome. Although A-FABP is thought to be a cytoplasmic protein, it is also detectable in the human bloodstream. Recent evidence showed that circulating A-FABP level to be an independent predictor of the development of metabolic syndrome and diabetes.Objective: The association of A-FABP with obesity and the decrease of its level after laparoscopic omega loop gastric bypass as indicator of improvement of metabolic syndrome.Patients and methods: Sixty-five morbid-obese patients had laparoscopic omega loop gastric bypass at Ain Shams University Hospitals and cure hospital from February 2018 to June 2019 with a mean age of 42.5±9.6 years were included in the study with comparative to non-obese control group. The A-FABP was measured before Laparoscopic omega loop gastric bypass and after 1 year of follow-up.Results: FABP1 levels in the obese 10.5 (8.25-14.25) P < 0.01, as compared to the control group 1.5 (0.675-2.625) analysis revealed that the FABP1 levels were positively correlated with BMI (P < 0.01). After weight loss, A-FABP plasmatic levels decreased significantly [3.4 (0.2-6)] ) P < 0.01.With correlation to improvement of the laboratory investigations of the metabolic syndrome fasting, 2 hours postprandialblood glucose level (2hPP) and glycated hemoglobin (HbA1) cholesterol, triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C)} fasting serum insulin level. Highly sensitive C-reactive protein (hsCRP). Were also analyzed and they showed a significant difference between the obese patients and 1 year after surgery. Conclusion: Serum A -FABP1 levels are markedly associated with obesity and correlated with an increase in BMI, and it markedly decreased with weight loss after omega loop gastric bypass.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: